3-Bromo-2-(4-fluorophenyl)indazole, 98%, 500mg

(3'-Methyl-[1,1'-biphenyl]-4-yl)methanamine hydrochloride, 95%, 1g

4-Methylpyrimidine, 98.0%, 10g

(3aR,4R,6aS)-5-benzyl-4-(((tert-butyldimethylsilyl)oxy)methyl)-2,2-dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyrrole, 98%, 50mg

Reversible frit 1000 ml, 1 (100 – 160 μm), 1 Piece

4-Chloro-3-nitrobenzoic acid, 95.0%, 1kg

2-(1H-Pyrrol-1-yl)-1-ethanamine, 95.0%, 100mg

1-(2,4-Dimethoxyphenyl)-N-methylmethanamine, 95.0%, 1g

2-Pyrrolidin-1-yl-benzaldehyde, 95.0%, 5g

1-(methoxymethyl)cyclopropanecarboxylic acid, 95.0%, 100mg

2-(5,6-Difluoro-1H-indol-3-yl)acetic acid, 95.0%, 10g

7-BROMO-5-NITRO-1H-INDAZOLE, 95%, 100mg

(1S,2R)-2-(Benzyloxymethyl)-1-hydroxy-3-cyclopentene, 90.0%, 1g